The PCNA-associated factor KIAA0101/p15PAF binds the potential tumor suppressor product p33ING1b

Experimental Cell Research

Volumn 312, Issue 1, 2006, Pages 73-85

  Simpson, Fiona ^a   Lammerts Van Bueren, Kelly ^a   Butterfield, Natalie ^a   Bennetts, Jennifer S ^a   Bowles, Josephine ^a   Adolphe, Christelle ^a   Simms, Lisa A ^b   Young, Joanne ^b,c   Walsh, Michael D ^b,c   Leggett, Barbara ^b   Fowles, Lindsay F ^a   Wicking, Carol ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Royal Brisbane and Womens Hospital Research Foundation   (Australia)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Colorectal tumor; KIAA0101; OEATC 1; p15PAF; p33ING1b; PCNA; UV irradiation

Indexed keywords

CYCLINE; DNA; POLYCLONAL ANTISERUM; PROTEIN P15; PROTEIN P15PAF; PROTEIN P21WAF; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL LINE; CONTROLLED STUDY; DNA REPAIR; DNA REPLICATION; GENE OVEREXPRESSION; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; TUMOR SUPPRESSOR GENE; ULTRAVIOLET RADIATION;

ANIMALIA; MAMMALIA;

EID: 27944490900     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2005.09.020     Document Type: Article

References (41)

1. PAF, a novel PCNA associated factor with increased expression in tumor tissues Oncogene 20 2001 484 489
2. K. Mizutani, M. Onda, S. Asaka, J. Akaishi, S. Miyamoto, A. Yoshida, M. Nagahama, K. Ito, and M. Emi Overexpressed in anaplastic thyroid carcinoma-1 (OEATC-1) as a novel gene responsible for anaplastic thyroid carcinoma Cancer 103 2005 1785 1790
3. D.A. Notterman, U. Alon, A.J. Sierk, and A.J. Levine Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays Cancer Res. 61 2001 3124 3130
4. C. Fleischmann, S. Bevan, J.C. Neil, A. Terry, and R.S. Houlston Mutations in the candidate tumour suppressor gene FLJ12973 on chromosome 15q15 are rare in colorectal cancer Cancer Lett. 196 2003 65 67
5. Y. Li, and Y. Chen Molecular cloning and characterization of LCRG1, a novel gene localized to the tumor suppressor locus D17S800-D17S930 Cancer Lett. 209 2004 75 85
6. T. Knosel, K. Schluns, U. Stein, H. Schwabe, P.M. Schlag, M. Dietal, and I. Petersen Genetic imbalances with impact on survival in colorectal cancer patients Histopathology 43 2003 323 331
7. T. Paunesku, S. Mittal, M. Protic, J. Oryhon, S.V. Korolev, A. Joachimiak, and G.E. Woloschak Proliferating cell nuclear antigen (PCNA): ringmaster of the genome Int. J. Radiat. Biol. 77 2001 1007 1021
8. Y. Wang, D. Cortez, P. Yazdi, N. Neff, S.J. Elledge, and J. Qin BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of abberant DNA structures Genes Dev. 14 2000 927 939
9. S. Waga, G.J. Hannon, D. Beach, and B. Stillman The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA Nature 369 1994 574 578
10. D.I. Zheleva, N.Z. Zhelev, P.M. Fischer, S.V. Duff, E. Warbrick, D.G. Blake, and D.P. Lane A quantitative study of the in vitro binding of the C-terminal domain of p21 to PCNA: affinity, stoichiometry, and thermodynamics Biochemistry 39 2000 7388 7397
11. I.T. Chen, M. Akamatsu, M.L. Smith, F.D. Lung, D. Duba, P.P. Roller, A.J.J. Fornace, and P.M. O'Conner Characterisation of p21Cip1/Waf1 peptide domains required for cyclin/Cdk2 and PCNA interaction Oncogene 12 1996 595 607
12. V.N. Podust, L.M. Podust, F. Goubin, B. Ducommun, and U. Hubscher Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the cyclin-dependent kinase inhibitor p21 Biochemistry 34 1995 8869 8875
13. M. Bendjennat, J. Boulaire, T. Jascur, H. Brickner, V. Barbier, A. Sarasin, A. Fotedar, and R. Fotedar UV irradiation triggers ubiquitin-dependent degredation of p21 (WAF1) to promote DNA repair Cell 114 2003 599 610
14. M. Scott, P. Bonnefin, D. Vieyra, F.M. Boisvert, D. Young, D.P. Bazett-Jones, and K. Riabowol UV-induced binding of ING1 to PCNA regulates the induction of apoptosis J. Cell Sci. 114 2001 3455 3462
15. I. Garkavtsev, A. Kazarov, A. Gudkov, and K. Riabowol Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation Nat. Genet. 14 1996 415 420
16. X. Feng, Y. Hara, and K. Riabowol Different HATS of the ING1 gene family Trends Cell Biol. 12 2002 532 538
17. G.H. He, C.C. Helbing, M.J. Wagner, C.W. Sensen, and K. Riabowol Phylogenetic Analysis of the ING Family of PHD Finger Proteins Mol. Biol. Evol. 22 2005 104 116
18. K.J.J. Cheung, and G. Li p33ING1 enhances UVB-induced apoptosis in melanoma cells Exp. Cell Res. 279 2002 291 298
19. K.J. Cheung Jr., D. Mitchell, P. Lin, and G. Li The tumor suppressor candidate p33(ING1) mediates repair of UV-damaged DNA Cancer Res. 61 2001 4974 4977
20. D. Skowyra, M. Zeremski, N. Neznanov, M. Li, Y. Choi, M. Uesugi, C.A. Hauser, W. Gu, A.V. Gudkov, and J. Qin Differential association of products of alternative transcripts of the candidate tumor suppressor ING1 with the mSin3/HDAC1 transcriptional corepressor complex J. Biol. Chem. 276 2001 8734 8739
21. D. Vieyra, R. Loewith, M. Scott, P. Bonnefin, F.M. Boisvert, P. Cheema, S. Pastyryeva, M. Meijer, R.N. Johnston, D.P. Bazett-Jones, S. McMahon, M.D. Cole, D. Young, and K. Riabowol Human ING1 proteins differentially regulate histone acetylation J. Biol. Chem. 277 2002 29832 29839
22. M. Nagashima, M. Shiseki, K. Miura, K. Hagiwara, S.P. Linke, R. Pedeux, X.W. Wang, J. Yokota, K. Riabowol, and C.C. Harris DNA damage-inducible gene p33ING2 negatively regulates cell proliferation through acetylation of p53 Proc. Natl. Acad. Sci. U. S. A. 98 2001 9671 9676
23. K.J. Cheung Jr., and G. Li p33(ING1) enhances UVB-induced apoptosis in melanoma cells Exp. Cell Res. 279 2002 291 298
24. D. Vieyra, T. Toyama, Y. Hara, D. Boland, R. Johnston, and K. Riabowol ING1 isoforms differentially affect apoptosis in a cell-age dependent manner Cancer Res. 62 2002 4445 4452
25. D.S.Y. Tsuchimoto, K. Sakumi, K. Nishioka, M. Sasaki, T. Fujiwara, and Y. Nakabeppu Human APE2 protein is mostly localized in the nuclei and to some extent in the mitochondria, while nuclear APE2 is partly associated with proliferating cell nuclear antigen Nucleic Acids Res. 28 2001 2349 2360
26. K. Kameyama, C. Huang, D. Liu, D. Masuya, T. Nakashima, S. Sumitomo, Y. Takami, M. Kinoshita, and H. Yokomise Reduced ING1b gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients Clin. Cancer Res. 9 2003 4926 4934
27. E.I. Campos, K.J. Cheung Jr., A. Murray, S. Li, and G. Li The novel tumour suppressor gene ING1 is overexpressed in human melanoma cell lines Br. J. Dermatol. 146 2002 574 580
28. J. Sambrook, and D. Russel Molecular Cloning-A Laboratory Manual 2001 Cold Spring Harbor Laboratory Press
29. L.J. Page, and M.S. Robinson Targeting signals and subunit interactions in coated vesicle adaptor complexes J. Cell Biol. 131 1995 619 630
30. M.S. Robinson 100-kD coated vesicle proteins: molecular heterogeneity and intracellular distribution studied with monoclonal antibodies J. Cell Biol. 104 1987 887 895
31. F.S. Simpson, N.A. Bright, M.A. West, L.S. Newman, R.B. Darnell, and M.S. Robinson A novel adaptor-related protein complex J. Cell Biol. 133 1996 749 760
32. D. Spector, R.D. Goldman, and L.A. Leinwand Cells. A Laboratory Manual 1998 Cold Spring Harbor Laboratory Press New York
33. M. Scott, P. Bonnefin, D. Vieyra, F. Boisvert, D. Young, D.P. Bazett-Jones, and K. Riabowol UV-induced binding of ING1 to PCNA regulates the induction of apoptosis J. Cell Sci. 114 2001 3455 3462
34. W.S. Park, J.Y. Park, R.R. Oh, N.J. Yoo, S.H. Lee, M.S. Shin, H.K. Lee, S. Han, S.K. Yoon, S.Y. Kim, C. Choi, P.J. Kim, S.T. Oh, and J.Y. Lee A distinct tumor suppressor gene locus on chromosome 15q21.1 in sporadic form of colorectal cancer Cancer Res. 60 2000 70 73
35. J. Petroziello, A. Yamane, L. Westendorf, M. Thompson, C. McDonagh, C. Cerveny, C.L. Law, A. Wahl, and P. Carter Suppression subtractive hybridization and expression profiling identifies a unique set of genes overexpressed in non-small-cell lung cancer Oncogene 23 2004 7734 7745
36. B. Ren, H. Cam, Y. Takahashi, T. Volkert, J. Terragni, R.A. Young, and B.D. Dynlacht E2F integrates cell cycle progression with DNA repair, replication, and G2/M checkpoints Genes Dev. 16 2002 245 256
37. B. Chen, E.I. Campos, R. Crawford, M. Martinka, and G. Li Analyses of the tumour suppressor ING1 expression and gene mutation in human basal cell carcinoma Int. J. Oncol. 22 2003 927 931
38. D. Vieyra, D.L. Senger, T. Toyama, H. Muzik, P.M. Brasher, R.N. Johnston, K. Riabowol, and P.A. Forsyth Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors Clin. Cancer Res. 9 2003 5952 5961
39. G.S. Nouman, B. Angus, J. Lunec, S. Crosier, A. Lodge, and J.J. Anderson Comparative assessment expression of the inhibitor of growth 1 gene (ING1) in normal and neoplastic tissues Hybrid Hybridomics 21 2002 1 10
40. A. Taddei, C. Maison, D. Roche, and G. Almouzni Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetylases Nat. Cell Biol. 3 2001 114 120
41. D.D. Fischer, R. Cai, U. Bhatai, F.A. Asselbergs, C. Song, R. Terry, N. Trogani, R. Widmer, P. Atadja, and D. Cohen Isolation and characterisation of a novel class II histone deacetylase, HDAC10 J. Biol. Chem. 277 2002 6656 6666